Esa Rintala
Impact in
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
Papers in
- Surgery 20
- Bladder and Urothelial Cancer Treatments 16
- Urinary and Genital Oncology Studies 5
- Epidemiology 17
- Sepsis Diagnosis and Treatment 11
- Co-authors
- Timo J. Nevalainen (5 shared papers)Pirkko Kotilainen (8 shared papers)Olli-Pekka Seppälä (4 shared papers)Sverker Hellsten (3 shared papers)Vesa Rasi (3 shared papers)Einar Hannisdal (1 shared paper)Rolf Wahlqvist (2 shared papers)Per M. Hellström (1 shared paper)
- Journals
- Intensive Care Medicine (3 papers)Journal of Internal Medicine (2 papers)PLoS ONE (2 papers)Critical Care Medicine (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)
- Partner nations
- FinlandUnited StatesSweden
In The Last Decade
Esa Rintala
60 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 115
- Clinical Biochemistry 141
- Critical Care and Intensive Care Medicine 92
- Epidemiology 571
- Microbiology 105
- Urology 94
Countries citing papers authored by Esa Rintala
This map shows the geographic impact of Esa Rintala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esa Rintala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esa Rintala more than expected).
Fields of papers citing papers by Esa Rintala
This network shows the impact of papers produced by Esa Rintala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esa Rintala. The network helps show where Esa Rintala may publish in the future.
Co-authors
The 25 scholars most cited alongside Esa Rintala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group. | 1996 | 202 |
| 2 | 2007 | 189 | |
| 3 | 1998 | 115 | |
| 4 | 2000 | 107 | |
| 5 | 1992 | 85 | |
| 6 | Propionibacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome. | 1996 | 77 |
| 7 | 2003 | 75 | |
| 8 | 2020 | 73 | |
| 9 | 2011 | 73 | |
| 10 | 1998 | 69 | |
| 11 | 2013 | 68 | |
| 12 | 2005 | 65 | |
| 13 | 1991 | 55 | |
| 14 | 1993 | 53 | |
| 15 | 1993 | 53 | |
| 16 | Alternating mitomycin C and bacillus Calmette-Guerin instillation prophylaxis for recurrent papillary (stages Ta to T1) superficial bladder cancer. Finnbladder Group. | 1996 | 51 |
| 17 | 2005 | 50 | |
| 18 | 2012 | 48 | |
| 19 | 1992 | 48 | |
| 20 | Endotoxin, interleukin-6 and phospholipase-A2 as markers of sepsis in patients with hematological malignancies. | 1995 | 37 |
About Esa Rintala
Esa Rintala is a scholar working on Surgery, Epidemiology, Molecular Biology, Infectious Diseases and Oncology, having authored 65 papers that have together received 2.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (16 papers), Sepsis Diagnosis and Treatment (11 papers), Bacterial Identification and Susceptibility Testing (6 papers), Hematological disorders and diagnostics (5 papers), Urinary and Genital Oncology Studies (5 papers), Streptococcal Infections and Treatments (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Clinical Biochemistry (141 citations), Critical Care and Intensive Care Medicine (92 citations), Epidemiology (571 citations), Microbiology (105 citations) and Urology (94 citations). Esa Rintala has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Timo J. Nevalainen, Pirkko Kotilainen, Olli-Pekka Seppälä, Sverker Hellsten, Vesa Rasi, Einar Hannisdal, Rolf Wahlqvist, Per M. Hellström, J Nikoskelainen and Raija Uusitalo‐Seppälä. Their work appears in journals such as Intensive Care Medicine, Journal of Internal Medicine, PLoS ONE, Critical Care Medicine and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.